COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 17 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $346,000 | – | 21,156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 597,662 | $6,837,000 | 11.05% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 444,444 | $4,987,000 | 0.88% |
| VILLERE ST DENIS J & CO LLC | 265,997 | $2,984,000 | 0.18% |
| FNY Investment Advisers, LLC | 5,000 | $57,000 | 0.05% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 75,270 | $861,000 | 0.04% |
| ARK Investment Management | 228,657 | $2,566,000 | 0.01% |
| BROWN ADVISORY INC | 77,349 | $868,000 | 0.00% |
| UBS Group AG | 3,429 | $38,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 248 | $3,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 3,600 | $40,000 | 0.00% |